METHODS: The VA Boston serves as a regional referral center for both Pulmonary and Allergy patients with a catchment area encompassing the northern New England region. The Asthma clinic also delivers care via a network of community-based outpatient clinics throughout Massachusetts, Rhode Island, New Hampshire and Maine. Via this network, referring providers were educated about the principles behind BT and its benefits in the treatment of patients with uncontrolled severe persistent asthma despite maximal medical therapy. Pulmonologists at nearby VA Medical Centers were also individually contacted to aprise them of the availability of BT. Patients screened for bronchial thermoplasty were evaluated for immunotherapy and omalizumab. All were on maximal medical therapy and had continued asthma flares. Outreach to providers supporting the procedure included presentations on the principles of BT, its relationship to conventional diagnostic bronchoscopy as well as expectations for level of anesthesia and duration of the procedure. All treatments were performed under moderate to deep sedation with anesthesiology support. Patients were pre-treated with prednisone as per the AIR2 trial and received an anti-sialagogue as well as a cough suppressant on the day of the procedure. Pre- and post-procedure spirometry were obtained to verify that patient's were near their baseline lung function and that they were safe for discharge subsequent to the procedure.